How many boxes of Alpelisib do you usually need in a month?

Alpelisib (Alpelisib)-Piqray is an oral PI3Kα selective inhibitor, mainly used to treat patients with hormone receptor-positive, HER2-negative advanced breast cancer who carry PIK3CA mutations. The recommended adult dose is 300 mg taken orally once daily, which is two 150 mg film-coated tablets taken daily. Based on this standard dosage, the monthly dosage of the drug can be calculated from the tablet size. Each box of the European version of Piqray contains 56 tablets of 150mg, which just meets the medication needs for 28 consecutive days, so one box is usually needed a month. The Indian version has 28 tablets per box of 150mg, and each box corresponds to a 14-day course of treatment, so two boxes are needed a month.

In clinical use, actual patient drug consumption may vary due to individual tolerance, dosage adjustments, and side effect management. For example, if a patient experiences side effects such as high blood sugar, rash, or diarrhea while taking the drug, the doctor may recommend a temporary dose reduction or short-term discontinuation of the drug, which will affect the amount of medication required per month. At the same time, in order to ensure the continuity of treatment, patients need to arrange drug supply in advance to avoid interruption of treatment due to logistics or storage problems.

In addition,Piqray’s overseas procurement and price are also key concerns for patients. The price of the European version of the original drug is relatively high, while the Lao version of the generic drug is more advantageous in terms of price, the efficacy is basically the same as the original drug, and the packaging design is reasonable to facilitate long-term maintenance treatment. When choosing a purchasing channel, patients should consider their own economic conditions, medication cycle, and treatment plan to ensure a stable supply of drugs, and take the drugs in strict accordance with doctor's instructions to ensure efficacy and safety.

Generally speaking, the monthly dosage of Apelvis mainly depends on the dosage standard and tablet specifications. The European version requires one box per month, while the Indian version usually requires two boxes per month. In actual use, side effects adjustment, individual differences, and supply stability need to be considered to ensure continuous treatment, significant effects, and safe medication.

Reference materials:https://www.piqray.com/